Ratings Healwell AI Inc.

Equities

AIDX

CA42249X1006

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. Other stock markets 16:00:00 2025-07-18 EDT			5-day change	1st Jan Change
1.440 ^CAD	+1.41%		+4.35%	-31.75%

07-03	Healwell AI Inc. - Shareholder/Analyst Call
06-11	Healwell AI Inc. Announces Strategic Expansion into the U.S. Healthcare Market	CI

Summary: Healwell AI Inc.

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Highlights: Healwell AI Inc.

Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
Over the last twelve months, the sales forecast has been frequently revised upwards.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses: Healwell AI Inc.

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Low profitability weakens the company.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
The group usually releases earnings worse than estimated.

Ratings Chart: Healwell AI Inc.

Source: Surperformance

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Fundamentals (Composite)	Global Valuation (Composite)	Capi.($)
HEALWELL AI INC.	-	-	279M
VEEVA SYSTEMS INC.			46.13B
PRO MEDICUS LIMITED			22.36B
SECTRA AB			7.23B
RAYSEARCH LABORATORIES AB			1.28B
B-SOFT CO.,LTD.		-	1.22B
EVOLENT HEALTH, INC.		-	1.1B
Average			11.37B
Weighted average by Cap.

See all sector ratings

Investor (Composite)

Trader (Composite)

ESG MSCI

Financials

Revenue growth

EPS growth

Capital Efficiency (Composite)

Net Margin

Financial Health (Composite)

Valuation

P/E

EV/Revenue

EV/EBITDA

PBR

Dividend Yield

Revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

Revenue revisions (1 month)

EPS revisions (1 year)

EPS revisions (4 months)

Consensus

Analysts' buy/sell recommendations

Analysts' recommendations evolution (4 months)

Analysts' target price

Analysts' target price evolution (4 months)

Analysts' target price evolution (1 year)

Business Predictability

Surprise rates

Analysts' coverage

Analysts' recommendations divergence

Analysts' Target price divergence

Financial estimates divergence

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes